Aritro Sen, PhD, assistant professor, Department of Endocrinology and Metabolism at the University of Rochester, Rochester, N.Y., is one of 11 recipients of a 2016 – 2017 Ferring Innovation Grant.
Sen was awarded the grant based on his research paper, “Regulation of AMH expression by GDF9+BMP15 and FSH during follicular development as a novel therapeutic option.” Sen serves on the editorial board of the Society’s Endocrinology journal. His most recent article was featured in Endocrinology in March 2016, entitled “Leptin-Induced CART (Cocaine- and Amphetamine-Regulated Transcript) Is a Novel Intraovarian Mediator of Obesity-Related Infertility in Females.”
Ferring announced the recipients of the 2016-2017 Ferring Innovation Grants program, an annual initiative of the Ferring Research Institute (FRI) which provides grants of up to $100,000 for early stage research. The program focuses on novel extracellular drug targets addressable with peptides or proteins within Ferring’s core therapeutic areas: reproductive health, gastroenterology, urology, and endocrinology.
Sen received his undergraduate degree in Microbiology with minor in chemistry and zoology from Bangalore University in 2000 followed by a masters degree in 2002 in biochemistry from University of Calcutta, India. He joined the PhD program in cell and molecular biology at West Virginia University. Following his PhD in 2005, Sen moved to Michigan State University for a post-doctoral fellowship in molecular reproductive biology in the Department of Animal Sciences.
In 2008, Sen joined the laboratory of Stephen R. Hammes, PhD, MD, in the Division of Endocrinology and Metabolism at University of Texas Southwestern Medical Center, Dallas, for a second post-doctoral fellowship in molecular endocrinology and then in 2009 he moved from Dallas to Rochester, N.Y., to join the faculty as research assistant professor at the University of Rochester Medical Center. Sen also holds an adjunct faculty position at The College of Brockport, State University of New York and is a visiting research scientist at the Center for Human Reproduction in New York City.
Sen’s current research focuses on three closely related but distinct areas: (1) Understanding the role of androgens in ovarian physiology, (2) Mechanism of steroid actions in cancer development and progression, and (3) Determining local effects of obesity on ovarian function and identifying biomarkers for obesity related fertility problems.
In 2010, Sen received an Endocrine Society Outstanding Abstract Award at ENDO 2010 in San Diego, and in 2015 received the Endocrine Society’s Pfizer Early Career Investigator Award.
“We look forward to the outcomes of the research being carried out by our grant awardees,” says Keith James, president of FRI and senior vice president, research and development. “Ferring is committed to stimulating basic research, with the ultimate aim of developing innovative products that improve the lives of patients.”
Applications for the 2017-2018 Ferring Innovation Grants program will open in spring/summer 2017.